Valley Brook Capital Group’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Buy
4,772
+151
+3% +$10.8K 0.21% 84
2026
Q1
$325K Buy
4,621
+660
+17% +$48.7K 0.22% 85
2025
Q4
$294K Sell
3,961
-209
-5% -$15K 0.19% 96
2025
Q3
$279K Sell
4,170
-184
-4% -$11.9K 0.19% 93
2025
Q2
$278K Buy
4,354
+30
+0.7% +$1.91K 0.21% 94
2025
Q1
$295K Buy
4,324
+16
+0.4% +$1.1K 0.23% 91
2024
Q4
$282K Buy
4,308
+51
+1% +$3.54K 0.21% 97
2024
Q3
$310K Buy
4,257
+141
+3% +$10.1K 0.22% 94
2024
Q2
$282K Buy
4,116
+326
+9% +$22K 0.22% 96
2024
Q1
$264K Buy
3,790
+590
+18% +$40K 0.21% 97
2023
Q4
$207K Buy
+3,200
New +$195K 0.18% 108
2021
Q2
Sell
-1,875
Closed -$110K 208
2021
Q1
$110K Buy
1,875
+371
+25% +$21.9K 0.1% 152
2020
Q4
$86K Buy
+1,504
New +$83K 0.09% 156

Other funds holding FHLC

Valley Brook Capital Group's FHLC Position: Q2 2026 in Review

Valley Brook Capital Group increased its Fidelity MSCI Health Care Index ETF (FHLC) stake by 3.3% in Q2 2026, buying an estimated $10.8K and bringing the position to 4,772 shares worth $369K. The position accounts for 0.21% of the portfolio, ranked #84.

Valley Brook Capital Group first reported a position in FHLC in Q4 2020 and has held it in 13 quarters since. 219 funds tracked by Wall St. Rank hold FHLC as of Q2 2026.

  • Valley Brook Capital Group held 4,772 shares of Fidelity MSCI Health Care Index ETF worth $369K as of Q2 2026.
  • Valley Brook Capital Group bought 151 Fidelity MSCI Health Care Index ETF shares in Q2 2026, an estimated $10.8K.
  • Fidelity MSCI Health Care Index ETF made up 0.21% of Valley Brook Capital Group's portfolio in Q2 2026, its #84 holding.
  • Valley Brook Capital Group first reported a position in Fidelity MSCI Health Care Index ETF in Q4 2020 and has held it in 13 quarters since.
  • 219 funds tracked by Wall St. Rank held Fidelity MSCI Health Care Index ETF as of Q2 2026.

Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.